medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2010, Number 594

<< Back Next >>

Rev Med Cos Cen 2010; 67 (594)

Displasia broncopulmonar: Conceptos básicos

Rojas GA, Cordero GH

Language: Spanish
References: 17
Page: 357-361
PDF size: 265.85 Kb.


ABSTRACT

Bronchopulmonar dysplasia (BPD) is a chronic lung disease that occurs mainly in preterm infants that have needed mechanic ventilation and oxygen therapy to treat the acute respiratory distress, but it can also occur in immature infants who have had initial signs of pulmonary disease. The progress made on the neonatal care, have led to an increase in the survival rates of immature children; nevertheless, the incidence of BPD in the survivors seems to be rising in the last years, with an increase of the survival of the most immature children.


REFERENCES

  1. Ambalavanan N, Carlo W. Ventilatory Strategies in the Prevention and Management of Bonchopulmonary Dysplasia. Seminar in Perinatology 30:192-199, 2006.

  2. Andreson P, Doyle L. Neurodevelopmental Outcome of Bronchopulmonary Dysplasia. Seminars in perinatology 30:227-232,2006.

  3. Apkon M, Nehgme RA, Lister G. Cardiovascular Abnormalities in Bronchopulmonary Dysplasia. In chronic lung Disease of Infancy, 2000: 321-56.

  4. Bancalari E, Abdenour GE et al. Bronchopulmonary Dysplasia: clinical presentation. J Peditr 1979;95:819-23.

  5. Baveja R, Christou H. Pharmacological strategies in the prevention and management of Bronchopulmonary Dysplasia. Seminars in Perinatology 30:209-218, 2006.

  6. Biniwale M, Ehrenkranz R. The Role of nutrition in the Prevention and Management of Bronchopulmonary Dysplasia. Seminars in Perinatology 30:200-208,2006.

  7. Chess PR, D´Angio C et al. Pathogenesis of Bronchopulmonary Dysplasia. Seminars in Perynatology 30: 171–178. 2006.

  8. Ehrenkranz R, Walsh MC et al. Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia. Pediatrics vol. 116 (6): 1353-59.2005.

  9. Kinsella J, Greenough A. Bronchopulmonary dysplasia. Lancet 2006; 367:1421-31.

  10. Mahut B. Suivi respiratoire de l´enfant cronchodysplasique. Revue Francaise d´Allergologie et d´Immunologie Clinique. 45 (2005) 509-514.

  11. Northway WH, Rosand RC et al. Pulmonary Disease Following respiratory theraphy of hyaline membrane disease. N Engl J Med 1967; 1967; 276:357’68.

  12. Parker TA, Abman SH. The Pulmonary Circulation in Bronchopulmnary Dysplasia. Seminars of neonatology 2003; 8:51-61.

  13. Van Kaam A, Rimensberger P. Lung protective strategies in neonatology: What do we know- What do we need to know. Critical Care Medicine, 2007;35:925-931.

  14. Walsh NC, Szefler S et al. Summary proceedings From the Bronchopulmonay Dysplasia Grup. Pediatrics 117 (3): s52-s56, 2006.

  15. Walsh M, Yao Q. Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates. Pediatrics Vol 114 (5): 1305-12. 2004.

  16. Walsh MC, Yao Q et al. Changes in the use of postnatal Steroids for Bronchopulmonary Dysplasia in 3 Large Neonatal Netwoks. .pediatrics. www.pediatrics.org, 2006.

  17. Wolfson MR, Bhutani BK et al. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. Journals of Pediatrics 1984; 104: 752-57.




2020     |     www.medigraphic.com